Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    0.00 (0.00%)
Bid:
2,315.00
Ask:
2,320.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

17 Nov 2023 07:00

RNS Number : 7559T
RIT Capital Partners PLC
17 November 2023
Β 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

Β 

17 November 2023

Β 

31 October 2023 Net Asset Value

Β 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 31 October 2023 (with debt at fair value) was 2,362p per Β£1 ordinary share (30 September 2023: 2,409p). This is after deduction of the second interim dividend of 19p per Β£1 ordinary share paid on 27 October 2023.

Β 

Β 

October 2023 Highlights

Β 

Global equities retreated in October as higher bond yields and renewed geopolitical concerns put pressure on equity valuations. In the US, buoyant economic data reinforced a higher-for-longer rate environment which pushed the 10-year Treasury yield above 5% for the first time since 2007. The S&P 500 declined by -2.1% over the month, while weakening economic growth in the UK and Europe led to declines of -3.7% for the FTSE 100 and -3.6% for the STOXX 600. Investor sentiment towards China weakened, with the CSI 300 down -3.1%. Gold rallied by ~7.3% as investors sought safe haven assets, while the US dollar strengthened slightly in the month.

Β 

Our portfolio declined less than the markets driven by our moderate net equity exposure, positive contributions from our Uncorrelated Strategies as well as our meaningful US dollar position.

Β 

Β·

Our Quoted Equities book detracted during the month. Positive contributions from Japanese holdings were offset by weakness in certain value positions, alongside declines in our healthcare and Chinese holdings.

Β·

Private Investments were approximately flat for the month, with no major movements from the new marks received from our private funds for Q3. As of 31 October, 12% of private funds were valued at 30 September reported valuations and 83% were held at 30 June valuations, with the remainder held at 31 March. All private direct positions are valued at 30 June.

Β·

Our Uncorrelated Strategies book was steady in October. Our macro strategies and gold position contributed positively during the month, while credit strategies detracted.

Β·

The Board continued its active buyback programme, generating a further accretive impact to the NAV per share. In the month of October, the Company repurchased approximately 0.7 million shares on behalf of shareholders.

Β 

Β 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

Β 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

Β 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

Β 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Tom Burns

T:Β 020 7404 5959

E:Β RIT@BrunswickGroup.comΒ 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NAVVQLFFXFLEFBL
Date   Source Headline
12th Apr 20197:00 amRNSNet Asset Value(s)
3rd Apr 20193:59 pmRNSQUARTERLY DISCLOSURE - Listing Rule 15.6.8
22nd Mar 20194:01 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSNet Asset Value(s)
5th Mar 20197:00 amRNSAnnual Financial Report
18th Feb 20197:00 amRNSNet Asset Value(s)
5th Feb 20197:00 amRNSNet Asset Value(s)
8th Jan 201910:02 amRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Dec 20187:00 amRNSNet Asset Value(s)
30th Nov 201810:53 amRNSComposition of Board Committee
14th Nov 20187:00 amRNSNet Asset Value(s)
29th Oct 20184:59 pmRNSComposition of Board Committee
16th Oct 201811:11 amRNSDirector Declaration
12th Oct 20187:00 amRNSNet Asset Value(s)
5th Oct 20185:03 pmRNSDirector/PDMR Shareholding
4th Oct 20185:46 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Sep 20187:00 amRNSNet Asset Value(s)
24th Aug 20183:15 pmRNSAppointment of Joint Broker
14th Aug 20187:00 amRNSNet Asset Value(s)
7th Aug 20187:00 amRNSHalf-year Report
18th Jul 20187:00 amRNSNet Asset Value(s)
3rd Jul 20186:00 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Jun 20187:00 amRNSNet Asset Value(s)
15th May 20187:00 amRNSNet Asset Value(s)
26th Apr 201812:41 pmRNSDirectorate Change
26th Apr 201812:27 pmRNSResult of AGM
16th Apr 20187:25 amRNSNet Asset Value(s)
6th Apr 20185:54 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
28th Mar 20185:09 pmRNSDirector/PDMR Shareholding
26th Mar 201811:54 amRNSDirectorate Change
14th Mar 20187:00 amRNSNet Asset Value(s)
5th Mar 20186:00 pmRNSDirector/PDMR Shareholding
27th Feb 20187:00 amRNSFinal Results and Dividend
14th Feb 20187:00 amRNSNet Asset Value(s)
5th Feb 201810:02 amRNSInitiation research from QuotedData
31st Jan 20187:00 amRNSNet Asset Value(s)
22nd Dec 201710:08 amRNSDirector/PDMR Shareholding
22nd Dec 20177:00 amRNSDirectorate Change
20th Dec 20174:17 pmRNSDirector Declaration
14th Dec 20177:00 amRNSNet Asset Value(s)
27th Nov 20175:54 pmRNSDirector/PDMR Shareholding
16th Nov 20175:28 pmRNSComposition of Board Committee
14th Nov 20177:00 amRNSNet Asset Value(s)
19th Oct 20174:19 pmRNSDirectorate Change
16th Oct 20177:00 amRNSNet Asset Value(s)
14th Sep 20177:00 amRNSNet Asset Value(s)
14th Aug 20177:00 amRNSNet Asset Value(s)
14th Aug 20177:00 amRNSHalf-year Report
21st Jul 201710:00 amRNSDirectorate Change
18th Jul 20177:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.